![Targeting signaling pathways in prostate cancer: mechanisms and clinical trials | Signal Transduction and Targeted Therapy Targeting signaling pathways in prostate cancer: mechanisms and clinical trials | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-01042-7/MediaObjects/41392_2022_1042_Fig1_HTML.png)
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials | Signal Transduction and Targeted Therapy
![IJMS | Free Full-Text | Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment IJMS | Free Full-Text | Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment](https://www.mdpi.com/ijms/ijms-24-02289/article_deploy/html/images/ijms-24-02289-g001.png)
IJMS | Free Full-Text | Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
![Cancers | Free Full-Text | PI3K Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Current Status and Future Perspectives Cancers | Free Full-Text | PI3K Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Current Status and Future Perspectives](https://www.mdpi.com/cancers/cancers-14-01571/article_deploy/html/images/cancers-14-01571-g001.png)
Cancers | Free Full-Text | PI3K Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Current Status and Future Perspectives
![The biology behind PI3K inhibition in chronic lymphocytic leukaemia - Valentín Ortiz-Maldonado, Marcial García-Morillo, Julio Delgado, 2015 The biology behind PI3K inhibition in chronic lymphocytic leukaemia - Valentín Ortiz-Maldonado, Marcial García-Morillo, Julio Delgado, 2015](https://journals.sagepub.com/cms/10.1177/2040620714561581/asset/images/large/10.1177_2040620714561581-fig3.jpeg)